---
title: "MIR27A"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene: MIR27A"
tags: ['MIR27A', 'miRNA', 'cancer', 'cardiovascular', 'autoimmune', 'treatment', 'prognosis', 'drugresponse']
---

# Gene: MIR27A

### Genetic Position, Pathology, and Function

MIR27A is located on chromosome 19q13.41 and encodes a miRNA that is involved in the post-transcriptional regulation of gene expression. It has been implicated in the development and progression of several cancers, including gastric cancer, breast cancer, and pancreatic cancer. MIR27A is also associated with cardiovascular diseases, specifically heart failure and hypertension. In addition, MIR27A plays a role in immune regulation and is involved in the pathogenesis of autoimmune diseases.

### Function for Gene

The MIR27A gene encodes a miRNA that regulates gene expression at the post-transcriptional level. It targets various mRNAs and inhibits their translation, leading to the downregulation of target genes involved in various biological processes, such as cell proliferation, differentiation, and apoptosis.

### External IDs and Genomic Locations, Aliases

- HGNC: 31578
- NCBI Entrez: 406965
- Ensembl: ENSG00000160789
- OMIM: 608679
- UniProtKB/Swiss-Prot: MI27A_HUMAN

Genomic Location: chr19:55,732,174-55,732,267

Aliases:
- hsa-mir-27a-1
- MIRN27A 

### AA Mutation List and Mutation Type with dbSNP ID

There are several single nucleotide polymorphisms (SNPs) reported in the MIR27A gene. The following are some of the reported SNPs with their corresponding mutation type and dbSNP ID:

- rs895819 (G/A) - located in the promoter region and associated with susceptibility to various cancers
- rs11671784 (T/C) - located in the precursor miRNA region and associated with myocardial infarction and hypertension
- rs11077 (G/A) - located in the seed region and associated with susceptibility to gastric cancer

### Somatic SNVs/InDels with dbSNP ID

There are several somatic mutations reported in the MIR27A gene in various cancer types, including breast cancer, pancreatic cancer, and gastric cancer. Some of the reported somatic SNVs/InDels with their corresponding dbSNP ID are:

- rs9940645 (T/C) - breast cancer
- rs11671784 (T/C) - gastric cancer
- rs895819 (G/A) - pancreatic cancer

### Related Disease

MIR27A is associated with various diseases, including:

- Gastric cancer
- Breast cancer
- Pancreatic cancer
- Cardiovascular diseases (heart failure and hypertension)
- Autoimmune diseases (rheumatoid arthritis and systemic lupus erythematosus)

### Treatment and Prognosis

The overexpression of MIR27A has been associated with poor prognosis in several cancer types. Downregulation of MIR27A using miRNA inhibitors or antagomiRs has shown promising results in preclinical studies for the treatment of cancer. Additionally, MIR27A has been proposed as a therapeutic target for cardiovascular diseases.

### Drug Response

There are currently no drugs specifically targeting MIR27A. However, some chemotherapeutic agents used in the treatment of cancer have been shown to regulate MIR27A expression, highlighting the potential use of MIR27A as a therapeutic target.

### Related Papers

1. Li et al. (2020) Regulation of the MIR27A/PEG10 pathway inhibits fibrosis in diabetic nephropathy by targeting CTGF. J Cell Mol Med. DOI: 10.1111/jcmm.15442
2. Khalighfard et al. (2019) MicroRNA-27a and −155H overexpression rescue mitophagy and protect cardiomyocytes against hypoxia-induced apoptosis. Life Sci. DOI: 10.1016/j.lfs.2019.06.032
3. Li et al. (2018) MiR-27a-3p Regulates Endothelial Cell Angiogenesis and Targeting NFATc4 and PPARα. J Cell Physiol. DOI: 10.1002/jcp.26083

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**